X

Trial Profile

CONDISOX: Continued versus discontinued oxytocin stimulation of labour in a double-blind randomised controlled trial

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 09 Feb 2023

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Oxytocin (Primary)
Indications Labour induction
Focus Therapeutic Use
Acronyms CONDISOX

Most Recent Events

18 Jan 2023 Results examining the factors associated with unexpectedly high rates of conversion to open label oxytocin of continuation vs discontinuation of oxytocin infusion during induced labour, published in the BJOG: An International Journal of Obstetrics and Gynaecology
16 Jul 2020 Status changed from recruiting to completed.
06 Feb 2017 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com